A federal appeals panel handed down a ruling this morning that could be problematic for Obamacare. As just reported, “A judicial panel in a 2-1 ruling said such subsidies can be granted only to those people who bought insurance in an Obamacare exchange run by an individual state or the District of Columbia — not […]
A massive pay-off to Big Pharma disguised as a weapon in the culture war is still alive and well, no matter that a small group of “closely held” for-profit corporations managed to escape it this morning.
While Eric Cantor went down to a crushing defeat, a fellow Republican incumbent with half his tenure, a third his warchest, a more spread-out district, and a challenger with ties to a national organization cruised to re-election.
Unlike many of my fellow BD contributors, I do not think Eric Cantor should be renominated. However, I don’t think Dave Brat should be nominated either. One will win; neither deserve it.